Control group:Placebo of Baqi Lingmao formula + sorafenib

2 trials

Sponsors

Shuguang Hospial Affiliated to Shanghai University of TCM

Conditions

primary liver cancer

Early Phase 1

A multicenter clinical study of Ba qi ling mao formulation in the treatment of BCLC B / C stage of primary liver cancer

Active, not recruitingChiCTR2000036907

Shuguang Hospial Affiliated to Shanghai University of TCMprimary liver cancer

Start: 2020-10-01Updated: 2020-09-28

A multicenter clinical study of Ba qi ling mao formulation in the treatment of BCLC B / C stage of primary liver cancer

Active, not recruitingITMCTR2000003705

Shuguang Hospial Affiliated to Shanghai University of TCMprimary liver cancer

Start: 2020-10-01Updated: 2023-02-20